In a prospective study, 14 patients with primary non-oat cell lung carcinoma were treated with intraoperative Iodine'25 (I'25) implantation of the lung tumor via lateral thoracotomy or median sternotomy . Staging mediastinal node dissection was performed in each case. Patients were selected when wed
The treatment of carcinoma of the lung
β Scribed by Omar M. Salazar
- Publisher
- Elsevier Science
- Year
- 1979
- Tongue
- English
- Weight
- 59 KB
- Volume
- 5
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## BACKGROUND. The number of elderly people with small cell lung carcinoma (SCLC) is increasing and currently nearly 25% are older than 70 years. Elderly patients may not tolerate intensive therapy and, therefore, often do not receive such treatment. Additionally, age may be an independent predicto
## Abstract Nine patients with βlimitedβ (thoracic) smallβcell lung carcinoma were treated with combined chemotherapy and radiotherapy (involved field and prophylactic whole brain). Induction drugs were Vincristine, Adriamycin, and Cyclophosphamide; and Cyclophosphamide, Vincristine, and CCNU for m
## BACKGROUND. Lymphoepithelioma-like carcinoma (LELC) of the lung occurs at a higher frequency in Asian compared with Western patients. Its association with Epstein-Barr virus varies among different ethnic groups. ## METHODS. Nine patients with primary LELC of the lung treated at a single inst
The COPP regimen (cyclophosphamide, Oncovin, procarbazine, prednisone) was one of the first chemotherapy programs to prolong survival in small cell lung cancer (SCLC) significantly. Results with this regimen in 50 patients with SCLC show an overall median survival of 10 months. Survival was decrease